FindMyKOL
Clinical trialNCT03189836TerminatedPhase 1Interventional

Study of ACTR707 in Combination With Rituximab in Subjects With Relapsed or Refractory B Cell Lymphoma

SponsorCogent Biosciences, Inc.Enrollment26Lymphoma
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

This is a phase 1, multi-center, single-arm, open-label study evaluating the safety and anti-lymphoma activity of an autologous T cell product (ACTR707) in combination with rituximab in subjects with refractory or relapsed CD20+ B cell lymphoma.
clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

11 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Banner Md Anderson Cancer Center

    Gilbert, Arizona, United States

  • Yale University

    New Haven, Connecticut, United States

  • Emory University, Winship Cancer Institute

    Atlanta, Georgia, United States

  • Loyola University

    Maywood, Illinois, United States

  • Indiana Bone and Marrow Transplantation

    Indianapolis, Indiana, United States

  • University of Maryland

    Baltimore, Maryland, United States

  • University of Minnesota

    Minneapolis, Minnesota, United States

  • Ohio State University

    Columbus, Ohio, United States

  • Tennessee Oncology - Nashville

    Nashville, Tennessee, United States

  • the University of Texas Md Anderson Cancer Center

    Houston, Texas, United States

  • Medical College of Wisconsin

    Milwaukee, Wisconsin, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

ACTR707Rituximab →
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
4 Oct 2017
Primary completion
21 Sept 2020
Completion
21 Sept 2020
Last update posted
11 Oct 2021
Registered enrollment
26
Registry id
NCT03189836
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 4 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.